Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accrual, aggrieved, agonistic, AIRUIKA, ALPINE, Ambrx, AMG, Amgen, Amsterdam, analyze, antagonist, anthony, antitrust, AOCI, arrest, ASP, ASPEN, atezolizomab, azacytidine, Barcelona, barcode, BCMA, beta, BGC, BioAtla, biobanking, bioreactor, bipartisan, BiTE, blinatumomab, BLINCYTO, bodily, border, BPG, bribery, BRUKINSA, camrelizumab, Canada, carboplatin, carfilzomib, Castleman, Catalent, CCPA, CD, chapter, chemoradiotherapy, chest, chimeric, chromosome, CIP, Circuit, circumstance, cisplatin, cluster, coincide, collateral, collateralized, consecutive, CTCAE, culminate, cut, cyberattack, denosumab, dimensional, dinutuximab, disability, dMMR, dominated, doublet, driver, DSCSA, eczema, effector, EGFRvIII, elaborate, embody, entrance, epidemic, espionage, EUSA, explanation, explicitly, FAP, fluorouracil, franchise, GCTB, GEJ, gemcitabine, genuine, giant, Harmonization, HITECH, HLE, HNTE, hooper, ICML, idiopathic, Ig, IIIB, illegitimate, immunoreceptor, implicit, imprisonment, incapable, induction, injured, inline, inoperable, insolvency, Interbank, interstitial, interval, ITIM, KYMRIAH, landscape, Latin, left, legitimate, LIBOR, lodge, LOI, London, lymphoblastic, MAA, Macao, MAGNOLIA, malaise, malfunction, man, MapKure, mark, matrix, meantime, MedDRA, MEL, military, mismatch, missing, MO, Mobile, mPC, MTD, multicentric, murine, musculoskeletal, NaN, NCI, NE, noncurrent, Nov, NPC, nurse, NZ, odor, organising, Orlando, OS, outbreak, overturned, pemetrexed, Pharma, phosphoinositide, placebo, pledged, poorly, prompt, proper, PSMA, pulse, QARZIBA, Qilu, quarantine, RANK, RANKL, RCC, rDAL, readout, RECIST, redacting, regenerative, reluctant, resell, ROSEWOOD, RRMM, Seattle, seminar, SEQUOIA, siltuximab, simplification, skeletally, SM, sNDA, spinal, spread, SSTC, stake, standstill, subdural, substandard, supervisory, SYLVANT, TASE, taxonomy, TCJA, telecommunication, text, TIGIT, tisagenlecleucel, topline, trace, transportation, underway, unprecedented, unreasonable, urticaria, versa, vice, win, winner, winning, won, workplace, wrongdoing, Wuhan, XGEVA, Xiamen
Removed:
aberrant, abnormal, accommodation, acneiform, adjusting, alanine, Amy, assessable, autoimmune, Baker, baseline, confirmation, deferral, diffuse, distinguish, earned, entrusted, epithelial, equaled, expired, fallopian, fibrillation, freestanding, fundamental, glioblastoma, headache, hypothyroidism, IgM, intrinsic, kidney, landlord, leased, lessor, manufactory, mezzanine, mutually, nausea, objective, peritoneal, Peterson, plasma, possession, promissory, pty, purpura, ranging, repayable, resistance, SD, stable, step, strive, thrombocytopenia, timetable, transformation, tube, unpaid, vi, vomiting, week
Filing tables
Filing exhibits
Related press release
BGNE similar filings
Filing view
External links
Exhibit 21.1
Subsidiaries
Name of Subsidiary | Jurisdiction of Incorporation or Organization | Percentage of Ownership by the Registrant | |||
BeiGene 101 | Cayman Islands | 100 | % | ||
BeiGene AUS Pty Ltd. | Australia | 100 | % | ||
BeiGene (Beijing) Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene Biologics Co., Ltd. | People’s Republic of China | 95 | % | ||
BeiGene (Canada) ULC | Canada | 100 | % | ||
BeiGene ESP, S.L. | Spain | 100 | % | ||
BeiGene France Sarl | France | 100 | % | ||
BeiGene Germany GmbH | Germany | 100 | % | ||
BeiGene Guangzhou Biologics Manufacturing Co., Ltd. | People’s Republic of China | 95 | % | ||
BeiGene (Guangzhou) Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene (Hong Kong) Co., Limited | Hong Kong | 100 | % | ||
Beijing Innerway Bio-tech Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene (Italy) Sarl | Italy | 100 | % | ||
BeiGene Ireland Limited | Republic of Ireland | 100 | % | ||
BeiGene Korea Y.H. | Korea | 100 | % | ||
BeiGene Pharmaceuticals (Guangzhou) Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene Pharmaceutical (Shanghai) Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene (Shanghai) Co., Ltd. | People’s Republic of China | 95 | % | ||
BeiGene (Shanghai) Research & Development Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene Singapore Pte., Ltd. | Singapore | 100 | % | ||
BeiGene (Suzhou) Co., Ltd. | People’s Republic of China | 100 | % | ||
BeiGene Switzerland GmbH | Switzerland | 100 | % | ||
BeiGene (Taiwan) Limited | Republic of China | 100 | % | ||
BeiGene UK, Ltd. | United Kingdom | 100 | % | ||
BeiGene United Kingdom, Ltd. | United Kingdom | 100 | % | ||
BeiGene USA, Inc. | United States | 100 | % | ||
Mapkure, LLC | United States | 71 | % |